Retinoids: present role and future potential

di Evans, T R J, Kaye, S B
Pubblicazione 1999

Immune checkpoint inhibitors: new strategies to checkmate cancer

di Wilson, R. A. M., Evans, T. R. J., Fraser, A. R., Nibbs, R. J. B.
Pubblicato in Clin Exp Immunol (2017)

Small Molecules in the Venom of the Scorpion Hormurus waigiensis

di Evans, Edward R. J., McIntyre, Lachlan, Northfield, Tobin D., Daly, Norelle L., Wilson, David T.
Pubblicato in Biomedicines (2020)

In vitro evaluation of cancer-specific NF-κB-CEA enhancer–promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines

di Guo, X, Evans, T R J, Somanath, S, Armesilla, A L, Darling, J L, Schatzlein, A, Cassidy, J, Wang, W
Pubblicazione 2007

Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response

di Scott, L C, Evans, T R J, Cassidy, J, Harden, S, Paul, J, Ullah, R, O'Brien, V, Brown, R
Pubblicazione 2009

Synthesis, Structural and Pharmacological Characterizations of CIC, a Novel α-Conotoxin with an Extended N-Terminal Tail

di Giribaldi, Julien, Haufe, Yves, Evans, Edward R. J., Wilson, David T., Daly, Norelle L., Enjalbal, Christine, Nicke, Annette, Dutertre, Sébastien
Pubblicato in Mar Drugs (2021)

A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma

di Eatock, M M, Anthony, D A, El-Abassi, M, Wilson, P, Paul, J, Smith, M, Soukop, M, Evans, T R J
Pubblicazione 2000

Exploiting inflammation for therapeutic gain in pancreatic cancer

di Steele, C W, Jamieson, N B, Evans, T R J, McKay, C J, Sansom, O J, Morton, J P, Carter, C R
Pubblicazione 2013

A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract

di Graham, J. S., Boyd, K., Coxon, F. Y., Wall, L. R., Eatock, M. M., Maughan, T. S., Highley, M., Soulis, E., Harden, S., Bützberger-Zimmerli, P., Evans, T. R. J.
Pubblicato in BMC Res Notes (2016)

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

di Evans, T R J, Colston, K W, Lofts, F J, Cunningham, D, Anthoney, D A, Gogas, H, de Bono, J S, Hamberg, K J, Skov, T, Mansi, J L
Pubblicazione 2002

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

di Dalhoff, K, Dancey, J, Astrup, L, Skovsgaard, T, Hamberg, K J, Lofts, F J, Rosmorduc, O, Erlinger, S, Bach Hansen, J, Steward, W P, Skov, T, Burcharth, F, Evans, T R J
Pubblicazione 2003

Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)

di Convertino, Matteo, Church, Timothy R, Olsen, Geary W, Liu, Yang, Doyle, Eddie, Elcombe, Clifford R, Barnett, Anna L, Samuel, Leslie M, MacPherson, Iain R, Evans, Thomas R J
Pubblicato in Toxicol Sci (2018)

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

di Boss, D S, Glen, H, Beijnen, J H, Keesen, M, Morrison, R, Tait, B, Copalu, W, Mazur, A, Wanders, J, O'Brien, J P, Schellens, J H M, Evans, T R J
Pubblicazione 2012

Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?

di Cameron, D A, Anderson, A, Toy, E, Evans, T R J, Le Vay, J H, Kennedy, I C S, Grieve, R J, Perren, T J, Jones, A, Mansi, J, Crown, J, Leonard, R C F
Pubblicazione 2002

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

di Naumann, R. Wendel, Hollebecque, Antoine, Meyer, Tim, Devlin, Michael-John, Oaknin, Ana, Kerger, Joseph, López-Picazo, Jose M., Machiels, Jean-Pascal, Delord, Jean-Pierre, Evans, Thomas R.J., Boni, Valentina, Calvo, Emiliano, Topalian, Suzanne L., Chen, Tian, Soumaoro, Ibrahima, Li, Bin, Gu, Junchen, Zwirtes, Ricardo, Moore, Kathleen N.
Pubblicato in J Clin Oncol (2019)

Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme

di Lindsay, Colin R, Shaw, Emily C, Blackhall, Fiona, Blyth, Kevin G, Brenton, James D, Chaturvedi, Anshuman, Clarke, Noel, Dick, Craig, Evans, Thomas R J, Hall, Geoff, Hanby, Andrew M, Harrison, David J, Johnston, Stephen R D, Mason, Malcolm D, Morton, Dion, Newton-Bishop, Julia, Nicholson, Andrew G, Oien, Karin A, Popat, Sanjay, Rassl, Doris, Sharpe, Rowena, Taniere, Phillipe, Walker, Ian, Wallace, William A, West, Nicholas P, Butler, Rachel, Gonzalez de Castro, David, Griffiths, Mike, Johnson, Peter W M
Pubblicato in ESMO Open (2018)